GlaxoSmithKline Shareholders To Vote On Novartis AG Deal On Dec. 18
Britain's GlaxoSmithKline (GSK.L) has asked its shareholders to vote at a meeting on Dec. 18 on its proposed major deal with Switzerland's Novartis (NOVN.VX), which will see the two pharmaceutical group trade more than $20 billion of assets.
The transaction, which includes GSK buying Novartis' vaccines business, Novartis purchasing GSK's cancer drugs, and the two groups tying up in consumer healthcare, was unveiled in April.
Help employers find you! Check out all the jobs and post your resume.
The transaction, which includes GSK buying Novartis' vaccines business, Novartis purchasing GSK's cancer drugs, and the two groups tying up in consumer healthcare, was unveiled in April.
Help employers find you! Check out all the jobs and post your resume.